Researchers at Melbourne’s Baker Heart and Diabetes Institute have discovered a method that could eliminate the need for regular insulin injections.
The team led by Professor Sam El-Osta identified two drugs, previously approved by the U.S. Food and Drug Administration for rare cancers, that are capable of rapidly restoring insulin production in cells damaged by diabetes.





